ap 1 transcription factor subunit Search Results


92
MedChemExpress kinases jun transcription factor ap 1 junb junb proto oncogene kegg kyoto encyclopedia
Kinases Jun Transcription Factor Ap 1 Junb Junb Proto Oncogene Kegg Kyoto Encyclopedia, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/kinases jun transcription factor ap 1 junb junb proto oncogene kegg kyoto encyclopedia/product/MedChemExpress
Average 92 stars, based on 1 article reviews
kinases jun transcription factor ap 1 junb junb proto oncogene kegg kyoto encyclopedia - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier

93
Proteintech jun
Jun, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/jun/product/Proteintech
Average 93 stars, based on 1 article reviews
jun - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Boster Bio rabbit anti jun
Rabbit Anti Jun, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti jun/product/Boster Bio
Average 93 stars, based on 1 article reviews
rabbit anti jun - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

96
Proteintech rabbit anti c jun pab
Rabbit Anti C Jun Pab, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti c jun pab/product/Proteintech
Average 96 stars, based on 1 article reviews
rabbit anti c jun pab - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

93
Proteintech rabbit polyclonal anti c jun
A) Western blot analysis of MCF-7 cells labeled in situ with photomate (lane 1 and 4), photomate and SAHA (lane 3 and 5) or DMSO (lane 6), reacted with biotin azide tag, and enriched with streptavidin coated magnetic beads. Blot shows enriched fraction eluted off beads and 2.5% of input recognized by anti-HDAC1, 2 and 3 antibodies. B) Graph of the abundance of each class I HDAC in MCF-7 cells quantified by comparison of MCF-7 lysate to a standard curve of each recombinant class I HDACs; visualized by Western blot (Figure S1). C) MS/MS analysis of photomate enriched fractions, as in A). Pie chart on the right shows total number of proteins identified by MS/MS and the number that were specifically enriched when compared to a DMSO control and were decreased by at least 50% when co-treated with SAHA. On the left, bioinformatic annotation of enriched proteins. All specifically enriched proteins are shown in Table S1. D) Gel based visualization of MCF-7 cells labeled with photomate in situ followed by fractionation into cytosol (right) and nucleus (left). Probe staining is shown above, and antibody recognition of the same gel is shown below. Gels are in grey scale for clarity. E) Western blot analysis of HDAC3 co-immunoprecipitates. MDA-MB-231 cells, or MCF-7 cells were lysed and enriched with <t>polyclonal</t> anti-HDAC3 (Abcam) or rabbit IgG protein A bead conjugates (Lanes 2 and 3 respectively). Eluates were analyzed by western blot along with 10% of Input (Lane 1) and blotted with antibodies for complex components. F) Small interfering RNA knockdown of NCOR1 in MCF-7 cells. MCF-7 cells were transfected with siNCOR1 or siControl, followed by labeling with photomate and electrophoretic separation. Antibody recognition of transfected cells is shown above, followed by gel based visualization of photomate engagement of HDAC1and HDAC3 below. Cells were either incubated with photomate (Lane 1) or photomate and excess SAHA (Lane 2) after transfection. All results are representative of at least 3 independent experiments.
Rabbit Polyclonal Anti C Jun, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal anti c jun/product/Proteintech
Average 93 stars, based on 1 article reviews
rabbit polyclonal anti c jun - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Proteintech junb
Identification of TIRS regulatory mechanisms and key biomarkers. A LASSO-based feature selection, with the optimal lambda determined when the partial likelihood deviance reached the minimum value (left). SVM-RFE-based feature selection, with root mean square error (RMSE) reached the minimum value and R -squared reached the max value (mid). Venn diagram presented the intersection of key biomarkers obtained through both algorithms (right). B Aberrant expression profiles for key biomarkers in Abdominal Aortic Wall Dataset 1 (AAA n = 80 patients, control n = 10 healthy individuals; Student’s t -test). C ROC curve demonstrating the diagnostic efficacy <t>of</t> <t>FOSB,</t> <t>JUNB,</t> CST7, and TBC1D4 in Abdominal Aortic Wall Dataset 1. D Clinical impact plot illustrating the clinical utility of key biomarkers. The “Number high risk” curve closely aligns with the “Number high risk with the event” curve at each threshold probability, indicating exceptional predictive power. E Aberrant expression profiles for key biomarkers in Abdominal Aortic Wall Dataset 2 (AAA n = 9 patients, control n = 10 healthy individuals; Student’s t -test). F ROC curve validating the diagnostic efficacy of FOSB, JUNB, CST7, and TBC1D4 in Abdominal Aortic Wall Dataset 2. G Clinical impact plot demonstrating the clinical utility of key biomarkers. Again, the “Number high risk” curve is closely aligned with the “Number high risk with the event” curve at each threshold probability, highlighting the biomarkers’ strong predictive power. H Aberrant expression profiles for key biomarkers in Perivascular Adipose Tissue Dataset 3 (dilated n = 30, non-dilated n = 30; Student’s t -test). I ROC curve verifying the diagnostic efficacy of FOSB, JUNB, CST7, and TBC1D4 in Perivascular Adipose Tissue Dataset 3. J Impact plots reiterated superior predictive performance probability, indicating outstanding predictive capability
Junb, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/junb/product/Proteintech
Average 93 stars, based on 1 article reviews
junb - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Boster Bio pavecs
Identification of TIRS regulatory mechanisms and key biomarkers. A LASSO-based feature selection, with the optimal lambda determined when the partial likelihood deviance reached the minimum value (left). SVM-RFE-based feature selection, with root mean square error (RMSE) reached the minimum value and R -squared reached the max value (mid). Venn diagram presented the intersection of key biomarkers obtained through both algorithms (right). B Aberrant expression profiles for key biomarkers in Abdominal Aortic Wall Dataset 1 (AAA n = 80 patients, control n = 10 healthy individuals; Student’s t -test). C ROC curve demonstrating the diagnostic efficacy <t>of</t> <t>FOSB,</t> <t>JUNB,</t> CST7, and TBC1D4 in Abdominal Aortic Wall Dataset 1. D Clinical impact plot illustrating the clinical utility of key biomarkers. The “Number high risk” curve closely aligns with the “Number high risk with the event” curve at each threshold probability, indicating exceptional predictive power. E Aberrant expression profiles for key biomarkers in Abdominal Aortic Wall Dataset 2 (AAA n = 9 patients, control n = 10 healthy individuals; Student’s t -test). F ROC curve validating the diagnostic efficacy of FOSB, JUNB, CST7, and TBC1D4 in Abdominal Aortic Wall Dataset 2. G Clinical impact plot demonstrating the clinical utility of key biomarkers. Again, the “Number high risk” curve is closely aligned with the “Number high risk with the event” curve at each threshold probability, highlighting the biomarkers’ strong predictive power. H Aberrant expression profiles for key biomarkers in Perivascular Adipose Tissue Dataset 3 (dilated n = 30, non-dilated n = 30; Student’s t -test). I ROC curve verifying the diagnostic efficacy of FOSB, JUNB, CST7, and TBC1D4 in Perivascular Adipose Tissue Dataset 3. J Impact plots reiterated superior predictive performance probability, indicating outstanding predictive capability
Pavecs, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pavecs/product/Boster Bio
Average 93 stars, based on 1 article reviews
pavecs - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

94
Proteintech c jun n
Identification of TIRS regulatory mechanisms and key biomarkers. A LASSO-based feature selection, with the optimal lambda determined when the partial likelihood deviance reached the minimum value (left). SVM-RFE-based feature selection, with root mean square error (RMSE) reached the minimum value and R -squared reached the max value (mid). Venn diagram presented the intersection of key biomarkers obtained through both algorithms (right). B Aberrant expression profiles for key biomarkers in Abdominal Aortic Wall Dataset 1 (AAA n = 80 patients, control n = 10 healthy individuals; Student’s t -test). C ROC curve demonstrating the diagnostic efficacy <t>of</t> <t>FOSB,</t> <t>JUNB,</t> CST7, and TBC1D4 in Abdominal Aortic Wall Dataset 1. D Clinical impact plot illustrating the clinical utility of key biomarkers. The “Number high risk” curve closely aligns with the “Number high risk with the event” curve at each threshold probability, indicating exceptional predictive power. E Aberrant expression profiles for key biomarkers in Abdominal Aortic Wall Dataset 2 (AAA n = 9 patients, control n = 10 healthy individuals; Student’s t -test). F ROC curve validating the diagnostic efficacy of FOSB, JUNB, CST7, and TBC1D4 in Abdominal Aortic Wall Dataset 2. G Clinical impact plot demonstrating the clinical utility of key biomarkers. Again, the “Number high risk” curve is closely aligned with the “Number high risk with the event” curve at each threshold probability, highlighting the biomarkers’ strong predictive power. H Aberrant expression profiles for key biomarkers in Perivascular Adipose Tissue Dataset 3 (dilated n = 30, non-dilated n = 30; Student’s t -test). I ROC curve verifying the diagnostic efficacy of FOSB, JUNB, CST7, and TBC1D4 in Perivascular Adipose Tissue Dataset 3. J Impact plots reiterated superior predictive performance probability, indicating outstanding predictive capability
C Jun N, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c jun n/product/Proteintech
Average 94 stars, based on 1 article reviews
c jun n - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

90
Active Motif activator protein-1 (ap-1) activity elisa kit transamtm ap-1-c-jun
Identification of TIRS regulatory mechanisms and key biomarkers. A LASSO-based feature selection, with the optimal lambda determined when the partial likelihood deviance reached the minimum value (left). SVM-RFE-based feature selection, with root mean square error (RMSE) reached the minimum value and R -squared reached the max value (mid). Venn diagram presented the intersection of key biomarkers obtained through both algorithms (right). B Aberrant expression profiles for key biomarkers in Abdominal Aortic Wall Dataset 1 (AAA n = 80 patients, control n = 10 healthy individuals; Student’s t -test). C ROC curve demonstrating the diagnostic efficacy <t>of</t> <t>FOSB,</t> <t>JUNB,</t> CST7, and TBC1D4 in Abdominal Aortic Wall Dataset 1. D Clinical impact plot illustrating the clinical utility of key biomarkers. The “Number high risk” curve closely aligns with the “Number high risk with the event” curve at each threshold probability, indicating exceptional predictive power. E Aberrant expression profiles for key biomarkers in Abdominal Aortic Wall Dataset 2 (AAA n = 9 patients, control n = 10 healthy individuals; Student’s t -test). F ROC curve validating the diagnostic efficacy of FOSB, JUNB, CST7, and TBC1D4 in Abdominal Aortic Wall Dataset 2. G Clinical impact plot demonstrating the clinical utility of key biomarkers. Again, the “Number high risk” curve is closely aligned with the “Number high risk with the event” curve at each threshold probability, highlighting the biomarkers’ strong predictive power. H Aberrant expression profiles for key biomarkers in Perivascular Adipose Tissue Dataset 3 (dilated n = 30, non-dilated n = 30; Student’s t -test). I ROC curve verifying the diagnostic efficacy of FOSB, JUNB, CST7, and TBC1D4 in Perivascular Adipose Tissue Dataset 3. J Impact plots reiterated superior predictive performance probability, indicating outstanding predictive capability
Activator Protein 1 (Ap 1) Activity Elisa Kit Transamtm Ap 1 C Jun, supplied by Active Motif, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/activator protein-1 (ap-1) activity elisa kit transamtm ap-1-c-jun/product/Active Motif
Average 90 stars, based on 1 article reviews
activator protein-1 (ap-1) activity elisa kit transamtm ap-1-c-jun - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Active Motif activated proteins-1 (ap-1) transcription factor elisa kit
Identification of TIRS regulatory mechanisms and key biomarkers. A LASSO-based feature selection, with the optimal lambda determined when the partial likelihood deviance reached the minimum value (left). SVM-RFE-based feature selection, with root mean square error (RMSE) reached the minimum value and R -squared reached the max value (mid). Venn diagram presented the intersection of key biomarkers obtained through both algorithms (right). B Aberrant expression profiles for key biomarkers in Abdominal Aortic Wall Dataset 1 (AAA n = 80 patients, control n = 10 healthy individuals; Student’s t -test). C ROC curve demonstrating the diagnostic efficacy <t>of</t> <t>FOSB,</t> <t>JUNB,</t> CST7, and TBC1D4 in Abdominal Aortic Wall Dataset 1. D Clinical impact plot illustrating the clinical utility of key biomarkers. The “Number high risk” curve closely aligns with the “Number high risk with the event” curve at each threshold probability, indicating exceptional predictive power. E Aberrant expression profiles for key biomarkers in Abdominal Aortic Wall Dataset 2 (AAA n = 9 patients, control n = 10 healthy individuals; Student’s t -test). F ROC curve validating the diagnostic efficacy of FOSB, JUNB, CST7, and TBC1D4 in Abdominal Aortic Wall Dataset 2. G Clinical impact plot demonstrating the clinical utility of key biomarkers. Again, the “Number high risk” curve is closely aligned with the “Number high risk with the event” curve at each threshold probability, highlighting the biomarkers’ strong predictive power. H Aberrant expression profiles for key biomarkers in Perivascular Adipose Tissue Dataset 3 (dilated n = 30, non-dilated n = 30; Student’s t -test). I ROC curve verifying the diagnostic efficacy of FOSB, JUNB, CST7, and TBC1D4 in Perivascular Adipose Tissue Dataset 3. J Impact plots reiterated superior predictive performance probability, indicating outstanding predictive capability
Activated Proteins 1 (Ap 1) Transcription Factor Elisa Kit, supplied by Active Motif, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/activated proteins-1 (ap-1) transcription factor elisa kit/product/Active Motif
Average 90 stars, based on 1 article reviews
activated proteins-1 (ap-1) transcription factor elisa kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Sanyal Biotechnology elevated creb- and ap1-dependent transcription
Identification of TIRS regulatory mechanisms and key biomarkers. A LASSO-based feature selection, with the optimal lambda determined when the partial likelihood deviance reached the minimum value (left). SVM-RFE-based feature selection, with root mean square error (RMSE) reached the minimum value and R -squared reached the max value (mid). Venn diagram presented the intersection of key biomarkers obtained through both algorithms (right). B Aberrant expression profiles for key biomarkers in Abdominal Aortic Wall Dataset 1 (AAA n = 80 patients, control n = 10 healthy individuals; Student’s t -test). C ROC curve demonstrating the diagnostic efficacy <t>of</t> <t>FOSB,</t> <t>JUNB,</t> CST7, and TBC1D4 in Abdominal Aortic Wall Dataset 1. D Clinical impact plot illustrating the clinical utility of key biomarkers. The “Number high risk” curve closely aligns with the “Number high risk with the event” curve at each threshold probability, indicating exceptional predictive power. E Aberrant expression profiles for key biomarkers in Abdominal Aortic Wall Dataset 2 (AAA n = 9 patients, control n = 10 healthy individuals; Student’s t -test). F ROC curve validating the diagnostic efficacy of FOSB, JUNB, CST7, and TBC1D4 in Abdominal Aortic Wall Dataset 2. G Clinical impact plot demonstrating the clinical utility of key biomarkers. Again, the “Number high risk” curve is closely aligned with the “Number high risk with the event” curve at each threshold probability, highlighting the biomarkers’ strong predictive power. H Aberrant expression profiles for key biomarkers in Perivascular Adipose Tissue Dataset 3 (dilated n = 30, non-dilated n = 30; Student’s t -test). I ROC curve verifying the diagnostic efficacy of FOSB, JUNB, CST7, and TBC1D4 in Perivascular Adipose Tissue Dataset 3. J Impact plots reiterated superior predictive performance probability, indicating outstanding predictive capability
Elevated Creb And Ap1 Dependent Transcription, supplied by Sanyal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/elevated creb- and ap1-dependent transcription/product/Sanyal Biotechnology
Average 90 stars, based on 1 article reviews
elevated creb- and ap1-dependent transcription - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
DWK Life Sciences ap-1 transcription factor
Identification of TIRS regulatory mechanisms and key biomarkers. A LASSO-based feature selection, with the optimal lambda determined when the partial likelihood deviance reached the minimum value (left). SVM-RFE-based feature selection, with root mean square error (RMSE) reached the minimum value and R -squared reached the max value (mid). Venn diagram presented the intersection of key biomarkers obtained through both algorithms (right). B Aberrant expression profiles for key biomarkers in Abdominal Aortic Wall Dataset 1 (AAA n = 80 patients, control n = 10 healthy individuals; Student’s t -test). C ROC curve demonstrating the diagnostic efficacy <t>of</t> <t>FOSB,</t> <t>JUNB,</t> CST7, and TBC1D4 in Abdominal Aortic Wall Dataset 1. D Clinical impact plot illustrating the clinical utility of key biomarkers. The “Number high risk” curve closely aligns with the “Number high risk with the event” curve at each threshold probability, indicating exceptional predictive power. E Aberrant expression profiles for key biomarkers in Abdominal Aortic Wall Dataset 2 (AAA n = 9 patients, control n = 10 healthy individuals; Student’s t -test). F ROC curve validating the diagnostic efficacy of FOSB, JUNB, CST7, and TBC1D4 in Abdominal Aortic Wall Dataset 2. G Clinical impact plot demonstrating the clinical utility of key biomarkers. Again, the “Number high risk” curve is closely aligned with the “Number high risk with the event” curve at each threshold probability, highlighting the biomarkers’ strong predictive power. H Aberrant expression profiles for key biomarkers in Perivascular Adipose Tissue Dataset 3 (dilated n = 30, non-dilated n = 30; Student’s t -test). I ROC curve verifying the diagnostic efficacy of FOSB, JUNB, CST7, and TBC1D4 in Perivascular Adipose Tissue Dataset 3. J Impact plots reiterated superior predictive performance probability, indicating outstanding predictive capability
Ap 1 Transcription Factor, supplied by DWK Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ap-1 transcription factor/product/DWK Life Sciences
Average 90 stars, based on 1 article reviews
ap-1 transcription factor - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


A) Western blot analysis of MCF-7 cells labeled in situ with photomate (lane 1 and 4), photomate and SAHA (lane 3 and 5) or DMSO (lane 6), reacted with biotin azide tag, and enriched with streptavidin coated magnetic beads. Blot shows enriched fraction eluted off beads and 2.5% of input recognized by anti-HDAC1, 2 and 3 antibodies. B) Graph of the abundance of each class I HDAC in MCF-7 cells quantified by comparison of MCF-7 lysate to a standard curve of each recombinant class I HDACs; visualized by Western blot (Figure S1). C) MS/MS analysis of photomate enriched fractions, as in A). Pie chart on the right shows total number of proteins identified by MS/MS and the number that were specifically enriched when compared to a DMSO control and were decreased by at least 50% when co-treated with SAHA. On the left, bioinformatic annotation of enriched proteins. All specifically enriched proteins are shown in Table S1. D) Gel based visualization of MCF-7 cells labeled with photomate in situ followed by fractionation into cytosol (right) and nucleus (left). Probe staining is shown above, and antibody recognition of the same gel is shown below. Gels are in grey scale for clarity. E) Western blot analysis of HDAC3 co-immunoprecipitates. MDA-MB-231 cells, or MCF-7 cells were lysed and enriched with polyclonal anti-HDAC3 (Abcam) or rabbit IgG protein A bead conjugates (Lanes 2 and 3 respectively). Eluates were analyzed by western blot along with 10% of Input (Lane 1) and blotted with antibodies for complex components. F) Small interfering RNA knockdown of NCOR1 in MCF-7 cells. MCF-7 cells were transfected with siNCOR1 or siControl, followed by labeling with photomate and electrophoretic separation. Antibody recognition of transfected cells is shown above, followed by gel based visualization of photomate engagement of HDAC1and HDAC3 below. Cells were either incubated with photomate (Lane 1) or photomate and excess SAHA (Lane 2) after transfection. All results are representative of at least 3 independent experiments.

Journal: Cell chemical biology

Article Title: Divergent JNK Phosphorylation of HDAC3 in Triple Negative Breast Cancer Cells Determines HDAC Inhibitor Binding and Selectivity

doi: 10.1016/j.chembiol.2017.08.015

Figure Lengend Snippet: A) Western blot analysis of MCF-7 cells labeled in situ with photomate (lane 1 and 4), photomate and SAHA (lane 3 and 5) or DMSO (lane 6), reacted with biotin azide tag, and enriched with streptavidin coated magnetic beads. Blot shows enriched fraction eluted off beads and 2.5% of input recognized by anti-HDAC1, 2 and 3 antibodies. B) Graph of the abundance of each class I HDAC in MCF-7 cells quantified by comparison of MCF-7 lysate to a standard curve of each recombinant class I HDACs; visualized by Western blot (Figure S1). C) MS/MS analysis of photomate enriched fractions, as in A). Pie chart on the right shows total number of proteins identified by MS/MS and the number that were specifically enriched when compared to a DMSO control and were decreased by at least 50% when co-treated with SAHA. On the left, bioinformatic annotation of enriched proteins. All specifically enriched proteins are shown in Table S1. D) Gel based visualization of MCF-7 cells labeled with photomate in situ followed by fractionation into cytosol (right) and nucleus (left). Probe staining is shown above, and antibody recognition of the same gel is shown below. Gels are in grey scale for clarity. E) Western blot analysis of HDAC3 co-immunoprecipitates. MDA-MB-231 cells, or MCF-7 cells were lysed and enriched with polyclonal anti-HDAC3 (Abcam) or rabbit IgG protein A bead conjugates (Lanes 2 and 3 respectively). Eluates were analyzed by western blot along with 10% of Input (Lane 1) and blotted with antibodies for complex components. F) Small interfering RNA knockdown of NCOR1 in MCF-7 cells. MCF-7 cells were transfected with siNCOR1 or siControl, followed by labeling with photomate and electrophoretic separation. Antibody recognition of transfected cells is shown above, followed by gel based visualization of photomate engagement of HDAC1and HDAC3 below. Cells were either incubated with photomate (Lane 1) or photomate and excess SAHA (Lane 2) after transfection. All results are representative of at least 3 independent experiments.

Article Snippet: Rabbit polyclonal anti-c-Jun , Protein Tech , 10024-2-AP.

Techniques: Western Blot, Labeling, In Situ, Magnetic Beads, Comparison, Recombinant, Tandem Mass Spectroscopy, Control, Fractionation, Staining, Small Interfering RNA, Knockdown, Transfection, Incubation

KEY RESOURCES TABLE

Journal: Cell chemical biology

Article Title: Divergent JNK Phosphorylation of HDAC3 in Triple Negative Breast Cancer Cells Determines HDAC Inhibitor Binding and Selectivity

doi: 10.1016/j.chembiol.2017.08.015

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: Rabbit polyclonal anti-c-Jun , Protein Tech , 10024-2-AP.

Techniques: Virus, Recombinant, Protease Inhibitor, Bicinchoninic Acid Protein Assay, Software, Blocking Assay

Identification of TIRS regulatory mechanisms and key biomarkers. A LASSO-based feature selection, with the optimal lambda determined when the partial likelihood deviance reached the minimum value (left). SVM-RFE-based feature selection, with root mean square error (RMSE) reached the minimum value and R -squared reached the max value (mid). Venn diagram presented the intersection of key biomarkers obtained through both algorithms (right). B Aberrant expression profiles for key biomarkers in Abdominal Aortic Wall Dataset 1 (AAA n = 80 patients, control n = 10 healthy individuals; Student’s t -test). C ROC curve demonstrating the diagnostic efficacy of FOSB, JUNB, CST7, and TBC1D4 in Abdominal Aortic Wall Dataset 1. D Clinical impact plot illustrating the clinical utility of key biomarkers. The “Number high risk” curve closely aligns with the “Number high risk with the event” curve at each threshold probability, indicating exceptional predictive power. E Aberrant expression profiles for key biomarkers in Abdominal Aortic Wall Dataset 2 (AAA n = 9 patients, control n = 10 healthy individuals; Student’s t -test). F ROC curve validating the diagnostic efficacy of FOSB, JUNB, CST7, and TBC1D4 in Abdominal Aortic Wall Dataset 2. G Clinical impact plot demonstrating the clinical utility of key biomarkers. Again, the “Number high risk” curve is closely aligned with the “Number high risk with the event” curve at each threshold probability, highlighting the biomarkers’ strong predictive power. H Aberrant expression profiles for key biomarkers in Perivascular Adipose Tissue Dataset 3 (dilated n = 30, non-dilated n = 30; Student’s t -test). I ROC curve verifying the diagnostic efficacy of FOSB, JUNB, CST7, and TBC1D4 in Perivascular Adipose Tissue Dataset 3. J Impact plots reiterated superior predictive performance probability, indicating outstanding predictive capability

Journal: BMC Biology

Article Title: Machine learning combined with omics-based approaches reveals T-lymphocyte cellular fate imbalance in abdominal aortic aneurysm

doi: 10.1186/s12915-025-02400-x

Figure Lengend Snippet: Identification of TIRS regulatory mechanisms and key biomarkers. A LASSO-based feature selection, with the optimal lambda determined when the partial likelihood deviance reached the minimum value (left). SVM-RFE-based feature selection, with root mean square error (RMSE) reached the minimum value and R -squared reached the max value (mid). Venn diagram presented the intersection of key biomarkers obtained through both algorithms (right). B Aberrant expression profiles for key biomarkers in Abdominal Aortic Wall Dataset 1 (AAA n = 80 patients, control n = 10 healthy individuals; Student’s t -test). C ROC curve demonstrating the diagnostic efficacy of FOSB, JUNB, CST7, and TBC1D4 in Abdominal Aortic Wall Dataset 1. D Clinical impact plot illustrating the clinical utility of key biomarkers. The “Number high risk” curve closely aligns with the “Number high risk with the event” curve at each threshold probability, indicating exceptional predictive power. E Aberrant expression profiles for key biomarkers in Abdominal Aortic Wall Dataset 2 (AAA n = 9 patients, control n = 10 healthy individuals; Student’s t -test). F ROC curve validating the diagnostic efficacy of FOSB, JUNB, CST7, and TBC1D4 in Abdominal Aortic Wall Dataset 2. G Clinical impact plot demonstrating the clinical utility of key biomarkers. Again, the “Number high risk” curve is closely aligned with the “Number high risk with the event” curve at each threshold probability, highlighting the biomarkers’ strong predictive power. H Aberrant expression profiles for key biomarkers in Perivascular Adipose Tissue Dataset 3 (dilated n = 30, non-dilated n = 30; Student’s t -test). I ROC curve verifying the diagnostic efficacy of FOSB, JUNB, CST7, and TBC1D4 in Perivascular Adipose Tissue Dataset 3. J Impact plots reiterated superior predictive performance probability, indicating outstanding predictive capability

Article Snippet: The primary antibodies against FOSB (1:500, catalog No. ab184938, Abcam) and JUNB (1:50, catalog No. 10486–1-AP, Proteintech) were incubated overnight at 4 °C, followed by incubation with horseradish peroxidase conjugated secondary antibodies.

Techniques: Selection, Expressing, Control, Diagnostic Assay

Verification of key biomarkers. A Abdominal aortic wall and peripheral blood samples obtained from AAA patients. B Aberrant expression profiles for key biomarkers in the abdominal aortic wall (Inhouse Dataset 1; AAA n = 5 patients, control n = 4 healthy individuals). C ROC curve validating the diagnostic efficacy of FOSB, JUNB, CST7, and TBC1D4 in the abdominal aortic wall (Inhouse Dataset 1). D Clinical impact plot demonstrating the clinical utility of key biomarkers. The “Number high risk” curve closely aligns with the “Number high risk with the event” curve at each threshold probability, indicating exceptional predictive power. E Aberrant expression profiles for key biomarkers in peripheral blood (Inhouse Dataset 2; AAA n = 24 patients, control n = 15 healthy individuals). F ROC curve validating the diagnostic efficacy of FOSB, JUNB, CST7, and TBC1D4 in peripheral blood (Inhouse Dataset 2). G Clinical impact plot illustrating the clinical utility of key biomarkers. Again, the “Number high risk” curve remains closely aligned with the “Number high risk with the event” curve at each threshold probability, highlighting the biomarkers’ strong predictive capability. H Mice were infused with saline or Ang II (1000 ng/kg/min) + BAPN. Gross abdominal aorta images were shown. Scale bar is 1 cm. I Representative images of immunohistochemical stains for elastin fiber (Van Gieson) and representative photomicrographs of hematoxylin and eosin (H&E) staining. Scale bar is 200 μm. J – L Representative immunohistochemical staining of FOSB and JUNB in aortic cross sections. Scale bar is 50 μm. Data are expressed as mean ± SEM (control n = 3 mice, AAA n = 5 or 6 mice). Student’s t -test was utilized to compare continuous variables between the two groups

Journal: BMC Biology

Article Title: Machine learning combined with omics-based approaches reveals T-lymphocyte cellular fate imbalance in abdominal aortic aneurysm

doi: 10.1186/s12915-025-02400-x

Figure Lengend Snippet: Verification of key biomarkers. A Abdominal aortic wall and peripheral blood samples obtained from AAA patients. B Aberrant expression profiles for key biomarkers in the abdominal aortic wall (Inhouse Dataset 1; AAA n = 5 patients, control n = 4 healthy individuals). C ROC curve validating the diagnostic efficacy of FOSB, JUNB, CST7, and TBC1D4 in the abdominal aortic wall (Inhouse Dataset 1). D Clinical impact plot demonstrating the clinical utility of key biomarkers. The “Number high risk” curve closely aligns with the “Number high risk with the event” curve at each threshold probability, indicating exceptional predictive power. E Aberrant expression profiles for key biomarkers in peripheral blood (Inhouse Dataset 2; AAA n = 24 patients, control n = 15 healthy individuals). F ROC curve validating the diagnostic efficacy of FOSB, JUNB, CST7, and TBC1D4 in peripheral blood (Inhouse Dataset 2). G Clinical impact plot illustrating the clinical utility of key biomarkers. Again, the “Number high risk” curve remains closely aligned with the “Number high risk with the event” curve at each threshold probability, highlighting the biomarkers’ strong predictive capability. H Mice were infused with saline or Ang II (1000 ng/kg/min) + BAPN. Gross abdominal aorta images were shown. Scale bar is 1 cm. I Representative images of immunohistochemical stains for elastin fiber (Van Gieson) and representative photomicrographs of hematoxylin and eosin (H&E) staining. Scale bar is 200 μm. J – L Representative immunohistochemical staining of FOSB and JUNB in aortic cross sections. Scale bar is 50 μm. Data are expressed as mean ± SEM (control n = 3 mice, AAA n = 5 or 6 mice). Student’s t -test was utilized to compare continuous variables between the two groups

Article Snippet: The primary antibodies against FOSB (1:500, catalog No. ab184938, Abcam) and JUNB (1:50, catalog No. 10486–1-AP, Proteintech) were incubated overnight at 4 °C, followed by incubation with horseradish peroxidase conjugated secondary antibodies.

Techniques: Expressing, Control, Diagnostic Assay, Saline, Immunohistochemical staining, Staining